» Non-Financial

Company Directors
Company Advisors
New & Press Releases
Directors Share Dealings
Major Shareholders
Company Subsidiary Calendar of Future Events
Company Name Change
Company Status Change

» Analyst Spreadsheet

Quick View(PDF)
Trader(PDF)
Dossier(PDF)
Download Analyst Template
Analyst Spreadsheet
Download Master Template
Annual Master Spreadsheet
Quarterly Master Spreadsheet
Annual & Quaterly Master Spreadsheet
Valuation Model Template
Valuation Model Spreadsheet
Business Risk(PDF)
Credit Metrics(PDF)
Annual Reports

For all products and/or service inquiries or to learn more about how WVB customer service solutions can reduce your service costs while increasing customer satisfaction, email us at .

GENEBIOTECH

WVB Number : KOR000040628 Country : Republic of Korea
SIC categorization : PREP FEED ANMLS-EX DOGS,CATS (2048) ISIN : KR7086060001
FT categorization : DIV'D INDUSTRIAL MANUFACTURING (591)  
Company status: ACTIVE  

» Corporation Profile :

Profile in brief:
The Company is a Korea-based company primarily engaged in the provision of fermented peptides and direct fed microbials. The Company provides four categories of products: PepSoyGen, a soy peptide used in animal feed; Natufermen, a direct fed microbial that helps digestion of nutrients for both human and animal; Lactocare, a direct fed microbial used as replacement for veterinary antibiotic and material for human medicine, and B-OATS, a bio starch used as additives for human medicine. It also provides animal proteins and functional additives. In addition, the Company provides formula feed related consulting services.
Phone : 82 04 1853 9961 Fax : 04 1853 9960
Chairman: : N/A Auditor : SHINWOO ACCOUNTING CORPORATION
CEO/Managing Director : YONG KOO KIM

» Company Facts

Net Profit Margin (%) 3.76  
Operating Margin (%) 4.70  
Return on Assets (%) 3.52  
Return on Equity (%) 5.60  
Employees 39  

» Company Financials

  Annual (2017)
Income Statement
('000 KRW )
Sales/Total Revenue 55,533,770  
EBITDA 4,132,467  
EBIT 2,543,070  
Net Income 2,089,008  
Balance Sheet
( '000 KRW)
Total Current Assets 30,971,411  
Total Assets 59,542,775  
Current Liabilities 12,245,519  
Total Liabilities & Debt 21,487,220  
Total Equity 38,055,555  
Cash & Flow
( '000 KRW)
Net Income/Staring Line 1,846,735  
Cash from Operating 1,132,376  
Cash from Investing -5,549,341  
Cash from Financing 1,257,978  
Cash & Equivalent Yr End 5,471,937